Actualités Aoxing Pharmaceutical Company New (delisted) - AXN | Actions American Stock Exchange

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Quarterly Report (10-q)

United States Securities and Exchange Commission Washington, D. C. 20549 FORM 10‑Q...

Annual Report (10-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________ FORM...

Notification That Annual Report Will Be Submitted Late (nt 10-k)

UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________...

Quarterly Report (10-q)

United States Securities and Exchange Commission Washington, D. C. 20549 FORM 10‑Q [X]...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule...

Proxy Statement (definitive) (def 14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule...

Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265%

Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265% Direct-To-Customer Sales Program Helps Raise Gross Margins To 79% PR...

Quarterly Report (10-q)

United States Securities and Exchange Commission Washington, D. C. 20549 FORM 10‑Q [X] QUARTERLY...

Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer

Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer PR Newswire FOSTER CITY, Calif., Feb. 1, 2016 FOSTER CITY, Calif., Feb. 1, 2016...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ FORM 8-K ______________ CURREN...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________ FORM 8-K ______________ CURRE...

Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of Shanghai

Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of Shanghai PR Newswire JERSEY CITY, N.J., Dec. 10, 2015 JERSEY...

Aoxing Pharma Announces Opening Of Government Funded Drug Research Center

Aoxing Pharma Announces Opening Of Government Funded Drug Research Center PR Newswire JERSEY CITY, N.J., Dec. 4, 2015 JERSEY CITY, N.J., Dec. 4...

Aoxing Pharma Announces Resignation of CFO

Aoxing Pharma Announces Resignation of CFO PR Newswire JERSEY CITY, N.J., Dec. 4, 2015 JERSEY CITY, N.J., Dec. 4, 2015 /PRNewswire/ -- Aoxing...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

	Prix en temps réel	Carnet d'ordres
BATS Europe
Chi-X Europe
Euronext

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aoxing Pharmaceutical Company New (delisted) (AXN)

Outils de qualité professionnelle, pour des investisseurs individuels.

AXN Actualités

Quarterly Report (10-q)

Annual Report (10-k)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement (definitive) (def 14a)

Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265%

Quarterly Report (10-q)

Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer

Current Report Filing (8-k)

Current Report Filing (8-k)

Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of Shanghai

Aoxing Pharma Announces Opening Of Government Funded Drug Research Center

Aoxing Pharma Announces Resignation of CFO

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Aoxing Pharmaceutical Company New (delisted) (AXN) Actualités

Aoxing Pharmaceutical Company New (delisted) (AXN)

Outils de qualité professionnelle, pour des investisseurs individuels.

AXN Actualités

Quarterly Report (10-q)

Annual Report (10-k)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Additional Proxy Soliciting Materials (definitive) (defa14a)

Proxy Statement (definitive) (def 14a)

Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265%

Quarterly Report (10-q)

Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer

Current Report Filing (8-k)

Current Report Filing (8-k)

Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of Shanghai

Aoxing Pharma Announces Opening Of Government Funded Drug Research Center

Aoxing Pharma Announces Resignation of CFO

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Vendredi fou

Jusqu'à 65% de réduction sur Intégral

Cours Euronext Niveau 1 et carnet d'ordres